Wells Fargo’s Vincerx Pharma, Inc. Warrant VINCW Stock Holding History

Wells Fargo’s Portfolio VINCW Stock Details VINCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,000	Closed	-$4K	–	7883
2021 Q1	$4K	Sell	1,000 -2,000	-67%	-$8.1K	﹤0.01%	6568
2020 Q4	$10K	Buy	+3,000	New	+$9.98K	﹤0.01%	6035

Wells Fargo's VINCW Position: Q2 2021 in Review

Wells Fargo sold out of Vincerx Pharma, Inc. Warrant (VINCW) in Q2 2021, closing a stake of 1,000 shares — an estimated $4K sold.

Wells Fargo first reported a position in VINCW in Q4 2020 and held it in 2 quarters. The position peaked at $10K in Q4 2020. 0 funds tracked by Wall St. Rank hold VINCW as of Q2 2021.

Wells Fargo reported no remaining Vincerx Pharma, Inc. Warrant position as of Q2 2021 after selling out during the quarter.
Wells Fargo sold 1,000 Vincerx Pharma, Inc. Warrant shares in Q2 2021, an estimated $4K.
Wells Fargo first reported a position in Vincerx Pharma, Inc. Warrant in Q4 2020 and held it in 2 quarters.
Wells Fargo's Vincerx Pharma, Inc. Warrant position peaked at $10K in Q4 2020.
0 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Warrant as of Q2 2021.

Based on Wells Fargo's 13F filing for Q2 2021, filed 16 Aug 2021.